Zexu Li
Key Laboratory Of Data Analytics And Optimization For Smart Industry
Shenyang, 110819, China
Shenyang, 110819, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Correction: Chemoresistance mechanisms to 5-Fluorouracil and reversal strategies in lung and breast cancer.
Journal: Scientific reports
Published: September 11, 2025
Author Correction: CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer.
Journal: Nature communications
Published: February 12, 2025
A comprehensive benchmark for multiple highly efficient base editors with broad targeting scope.
Journal: bioRxiv : the preprint server for biology
Published: January 07, 2025
Chemoresistance mechanisms to 5-Fluorouracil and reversal strategies in lung and breast cancer.
Journal: Scientific reports
Published: November 06, 2024
HNF4α-CDKL3 axis restricts MASLD progression by targeting FoxO1 via noncanonical phosphorylation.
Journal: Hepatology (Baltimore, Md.)
Published: April 15, 2024
CDKL3 is a targetable regulator of cell cycle progression in cancers.
Journal: The Journal of clinical investigation
Published: December 12, 2023
A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism.
Journal: Biochemical and biophysical research communications
Published: June 30, 2023
Modeling kidney development, disease, and plasticity with clonal expandable nephron progenitor cells and nephron organoids.
Journal: bioRxiv : the preprint server for biology
Published: June 09, 2023
Long-term expandable mouse and human-induced nephron progenitor cells enable kidney organoid maturation and modeling of plasticity and disease.
Journal: Cell stem cell
Published: May 11, 2023
USP10 strikes down β-catenin by dual-wielding deubiquitinase activity and phase separation potential.
Journal: Cell chemical biology
Published: February 10, 2023
CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer.
Journal: Nature communications
Published: January 17, 2023
Intrinsic targeting of host RNA by Cas13 constrains its utility.
Journal: Nature biomedical engineering
Published: August 04, 2022
Last Updated: 09/26/2026